![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
Thai Thanh Hoang Thi, Estelle J. A. Suys, Jung Seok Lee, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 359-359
Open Access | Times Cited: 348
Thai Thanh Hoang Thi, Estelle J. A. Suys, Jung Seok Lee, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 359-359
Open Access | Times Cited: 348
Showing 1-25 of 348 citing articles:
CRISPR in cancer biology and therapy
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 276
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 276
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
Emily H. Pilkington, Estelle J. A. Suys, Natalie L. Trevaskis, et al.
Acta Biomaterialia (2021) Vol. 131, pp. 16-40
Open Access | Times Cited: 190
Emily H. Pilkington, Estelle J. A. Suys, Natalie L. Trevaskis, et al.
Acta Biomaterialia (2021) Vol. 131, pp. 16-40
Open Access | Times Cited: 190
Current approaches of nanomedicines in the market and various stage of clinical translation
Xiaoting Shan, Xiang Gong, Jie Li, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 3028-3048
Open Access | Times Cited: 186
Xiaoting Shan, Xiang Gong, Jie Li, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 3028-3048
Open Access | Times Cited: 186
Nanoparticles in Drug Delivery: From History to Therapeutic Applications
Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Shahid Nadeem, et al.
Nanomaterials (2022) Vol. 12, Iss. 24, pp. 4494-4494
Open Access | Times Cited: 173
Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Shahid Nadeem, et al.
Nanomaterials (2022) Vol. 12, Iss. 24, pp. 4494-4494
Open Access | Times Cited: 173
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
Mantosh Kumar Satapathy, Ting‐Lin Yen, Jing‐Shiun Jan, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1183-1183
Open Access | Times Cited: 160
Mantosh Kumar Satapathy, Ting‐Lin Yen, Jing‐Shiun Jan, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1183-1183
Open Access | Times Cited: 160
Emerging Applications of Nanotechnology in Healthcare and Medicine
Shiza Malik, Khalid Muhammad, Yasir Waheed
Molecules (2023) Vol. 28, Iss. 18, pp. 6624-6624
Open Access | Times Cited: 160
Shiza Malik, Khalid Muhammad, Yasir Waheed
Molecules (2023) Vol. 28, Iss. 18, pp. 6624-6624
Open Access | Times Cited: 160
RNA therapy: rich history, various applications and unlimited future prospects
Young‐Kook Kim
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 455-465
Open Access | Times Cited: 158
Young‐Kook Kim
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 455-465
Open Access | Times Cited: 158
Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities
Brijendra Kumar Kashyap, Virendra Singh, Manoj Kumar Solanki, et al.
ACS Omega (2023) Vol. 8, Iss. 16, pp. 14290-14320
Open Access | Times Cited: 139
Brijendra Kumar Kashyap, Virendra Singh, Manoj Kumar Solanki, et al.
ACS Omega (2023) Vol. 8, Iss. 16, pp. 14290-14320
Open Access | Times Cited: 139
Superparamagnetic iron oxide nanoparticles for magnetic hyperthermia: recent advancements, molecular effects, and future directions in the omics era
Carlotta Pucci, Andrea Degl’Innocenti, Melike Belenli Gümüş, et al.
Biomaterials Science (2022) Vol. 10, Iss. 9, pp. 2103-2121
Open Access | Times Cited: 107
Carlotta Pucci, Andrea Degl’Innocenti, Melike Belenli Gümüş, et al.
Biomaterials Science (2022) Vol. 10, Iss. 9, pp. 2103-2121
Open Access | Times Cited: 107
Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines
Despo Chatzikleanthous, Derek T. O’Hagan, Roberto Adamo
Molecular Pharmaceutics (2021) Vol. 18, Iss. 8, pp. 2867-2888
Open Access | Times Cited: 98
Despo Chatzikleanthous, Derek T. O’Hagan, Roberto Adamo
Molecular Pharmaceutics (2021) Vol. 18, Iss. 8, pp. 2867-2888
Open Access | Times Cited: 98
Smart drug delivery systems for precise cancer therapy
Xiaoyou Wang, Chong Li, Yiguang Wang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4098-4121
Open Access | Times Cited: 97
Xiaoyou Wang, Chong Li, Yiguang Wang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4098-4121
Open Access | Times Cited: 97
Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid Delivery
Da Sun, Zheng‐Rong Lu
Pharmaceutical Research (2023) Vol. 40, Iss. 1, pp. 27-46
Open Access | Times Cited: 94
Da Sun, Zheng‐Rong Lu
Pharmaceutical Research (2023) Vol. 40, Iss. 1, pp. 27-46
Open Access | Times Cited: 94
Gold Complexes in Anticancer Therapy: From New Design Principles to Particle‐Based Delivery Systems
Guillermo Moreno‐Alcántar, Pierre Picchetti, Angela Casini
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 22
Open Access | Times Cited: 92
Guillermo Moreno‐Alcántar, Pierre Picchetti, Angela Casini
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 22
Open Access | Times Cited: 92
Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges
Vivek P. Chavda, Aayushi Patel, Kavya J. Mistry, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 79
Vivek P. Chavda, Aayushi Patel, Kavya J. Mistry, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 79
Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines
Eugenia D. Namiot, Aleksandr V. Sokolov, Vladimir N. Chubarev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 787-787
Open Access | Times Cited: 70
Eugenia D. Namiot, Aleksandr V. Sokolov, Vladimir N. Chubarev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 787-787
Open Access | Times Cited: 70
Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 221, pp. 112999-112999
Open Access | Times Cited: 68
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 221, pp. 112999-112999
Open Access | Times Cited: 68
Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona
Huan Tang, Ying Zhang, Tong Yang, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 9, pp. 1067-1077
Closed Access | Times Cited: 59
Huan Tang, Ying Zhang, Tong Yang, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 9, pp. 1067-1077
Closed Access | Times Cited: 59
Artificial nanovesicles for dsRNA delivery in spray‐induced gene silencing for crop protection
Lulu Qiao, Jonatan Niño‐Sánchez, Rachael Hamby, et al.
Plant Biotechnology Journal (2023) Vol. 21, Iss. 4, pp. 854-865
Open Access | Times Cited: 54
Lulu Qiao, Jonatan Niño‐Sánchez, Rachael Hamby, et al.
Plant Biotechnology Journal (2023) Vol. 21, Iss. 4, pp. 854-865
Open Access | Times Cited: 54
Solid lipid nanoparticles for targeted natural and synthetic drugs delivery in high-incidence cancers, and other diseases: Roles of preparation methods, lipid composition, transitional stability, and release profiles in nanocarriers’ development
Hamdoon A. Mohammed, Riaz Khan, Varsha Singh, et al.
Nanotechnology Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 50
Hamdoon A. Mohammed, Riaz Khan, Varsha Singh, et al.
Nanotechnology Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 50
Application of Nano-Delivery Systems in Lymph Nodes for Tumor Immunotherapy
Yiming Xia, Shunli Fu, Qingping Ma, et al.
Nano-Micro Letters (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 48
Yiming Xia, Shunli Fu, Qingping Ma, et al.
Nano-Micro Letters (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 48
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1305-1313
Open Access | Times Cited: 44
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1305-1313
Open Access | Times Cited: 44
STING Agonist-Derived LNP-mRNA Vaccine Enhances Protective Immunity Against SARS-CoV-2
Yuebao Zhang, Jinyue Yan, Xucheng Hou, et al.
Nano Letters (2023) Vol. 23, Iss. 7, pp. 2593-2600
Open Access | Times Cited: 42
Yuebao Zhang, Jinyue Yan, Xucheng Hou, et al.
Nano Letters (2023) Vol. 23, Iss. 7, pp. 2593-2600
Open Access | Times Cited: 42
A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient
Gretchen B. Schober, Sandra Story, Dev P. Arya
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Gretchen B. Schober, Sandra Story, Dev P. Arya
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Chemistry and Art of Developing Lipid Nanoparticles for Biologics Delivery: Focus on Development and Scale-Up
Rijo John, Jasmin monpara, Shankar Swaminathan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 131-131
Open Access | Times Cited: 22
Rijo John, Jasmin monpara, Shankar Swaminathan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 131-131
Open Access | Times Cited: 22
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 18
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 18